STAT: Ebola vaccine approved in Europe in landmark moment in fight against a deadly disease
“…The European Commission granted marketing authorization to Merck’s vaccine, known as Ervebo, on Monday, less than a month after the European Medicines Agency recommended it be licensed. It is currently being used in the Democratic Republic of the Congo under a ‘compassionate use’ or research protocol similar to a clinical trial…” (Branswell, 11/11).

Additional coverage of the vaccine’s European approval is available from CIDRAP News, Forbes, The Hill, and Reuters.